New injection for seasonal allergies in teens
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- You have had seasonal allergies for at least 2 years.
- You weigh at least 40 kg (about 88 pounds).
- Your allergy symptoms have been hard to control with nasal steroid sprays or other allergy medicines.
- You have not had a biologic injection (like Xolair) for allergies or asthma in the last 10 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication called stapokibart to help teenagers with seasonal allergic rhinitis (hay fever). The goal is to see if this treatment reduces allergy symptoms like sneezing, congestion, and itchy eyes during allergy season.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
This study tests a new injection called Stapokibart for people with seasonal allergic rhinitis (hay fever triggered by pollen or mold). The goal is to see if it helps control symptoms like sneezing, runny nose, and itchy eyes.
Stapokibart is a new injection that works on a key pathway involved in allergy symptoms. This study will test if this once-every-two-week shot can help reduce runny nose, sneezing, and itchy eyes in people with allergic rhinitis (hay fever).
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
Hear when a new Seasonal Allergic Rhinitis (SAR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.